Under the leadership of Vasant Narasimhan, the Executive Committee of Novartis (ECN) is responsible for overseeing the company's business operations. ECN members are chosen by the Board of Directors.

Download the Novartis organizational structure (PDF 0.2 MB)

Vasant (Vas) Narasimhan, M.D., Chief Executive Officer
Vasant (Vas) Narasimhan, M.D.
Chief Executive Officer
Shreeram Aradhye, President, Development and Chief Medical Officer
Shreeram Aradhye, M.D.
President, Development and Chief Medical Officer
Victor Bulto,  President, US
Victor Bulto
President, US
Aharon (Ronny) Gal, PhD, Chief Strategy & Growth Officer
Aharon (Ronny) Gal, Ph.D.
Chief Strategy & Growth Officer
Karen L. Hale, Chief Legal Officer
Karen L. Hale
Chief Legal Officer
Dr. Patrick Horber, President, International, since December 1, 2023
Patrick Horber, M.D.
President, International
Harry Kirsch, Chief Financial Officer
Harry Kirsch
Chief Financial Officer
Rob Kowalski, Chief People & Organization Officer
Rob Kowalski
Chief People & Organization Officer
Steffen Lang, Ph.D., President, Operations
Steffen Lang, Ph.D.
President, Operations
Fiona H. Marshall, Ph.D., President, Biomedical Research
Fiona H. Marshall, Ph.D.
President, Biomedical Research
Klaus Moosmayer, Ph.D., Chief Ethics, Risk and Compliance Officer
Klaus Moosmayer, Ph.D.
Chief Ethics, Risk & Compliance Officer

Other Members of Senior Management


Lutz Hegemann, M.D., Ph.D., President, Global Health & Sustainability
Lutz Hegemann, M.D., Ph.D.
President, Global Health and Swiss Country Affairs
Kees Roks, Chief Audit Officer
Kees Roks
Chief Audit Officer
Michelle Weese, Chief Corporate Affairs Officer
Michelle Weese
Chief Corporate Affairs Officer